Endpoints News

Endpoints News was founded in 2016 by John Carroll and Arsalan Arif to deliver the best news product in biopharma and become an essential read for industry leaders across the globe. Thanks to an ambitious team of journalists across the US, Europe and Asia and support from advertising partners, we're now read by thousands of innovative biotechs and every top 50 pharmaceutical company in the world. As a member of the Financial Times family, we're backed by the most respected global brand in business journalism and committed to providing advertisers with innovative ways to engage our growing audience of biopharma and healthcare executives across the globe.